Fundraising Fox

Longevity Fund

2 known investors

The Longevity Fund is a venture capital firm founded in 2011 to back founder-led biotech companies developing drugs for longevity and age-related diseases. It has since relaunched as a new fund under the name age1.

BiotechLongevity

Founders & leadership

LD
Laura DemingFounder
AC
Alex ColvilleGeneral Partner

Investors · 2

1517Telluride · $50K – $1M
age1reportedSan Francisco · $500K – $4M

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

The Longevity Fund | San Francisco Venture Capital | Altssaltss.com · Jun 2026Loyal Raises $100M Series C, Led by age1, to Advance the First Canine Longevity Drugbusinesswire.com · Feb 202611 Anti-Aging and Longevity Startups to Watch in 2026wewillcure.com · Dec 2025Longevity Fund is launching Age 1, a 4-month biotech seed programage1.com · Mar 2018Longevity Fund Raises $22M to Support Anti-Aging Therapieswsj.com · Aug 2017

Frequently asked questions

What does Longevity Fund do?
The Longevity Fund is a venture capital firm founded in 2011 to back founder-led biotech companies developing drugs for longevity and age-related diseases. It has since relaunched as a new fund under the name age1.
Who founded Longevity Fund?
Longevity Fund was founded by Laura Deming.
Who are Longevity Fund's investors?
Longevity Fund's investors include 1517, age1.